Envestnet Asset Management Inc. Has $25.67 Million Position in Encompass Health Co. (NYSE:EHC)

Envestnet Asset Management Inc. lowered its stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 10.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 277,976 shares of the company's stock after selling 33,312 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.28% of Encompass Health worth $25,671,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. MassMutual Private Wealth & Trust FSB grew its position in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after buying an additional 137 shares during the period. CBIZ Investment Advisory Services LLC lifted its stake in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after buying an additional 127 shares during the period. Tompkins Financial Corp bought a new stake in shares of Encompass Health in the 4th quarter valued at about $46,000. V Square Quantitative Management LLC grew its holdings in Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after purchasing an additional 177 shares during the period. Finally, Morse Asset Management Inc bought a new position in shares of Encompass Health during the third quarter worth $68,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. StockNews.com lowered shares of Encompass Health from a "buy" rating to a "hold" rating in a research note on Thursday, April 3rd. Barclays lifted their target price on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, February 7th. Royal Bank of Canada reissued an "outperform" rating and set a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. Finally, KeyCorp raised their target price on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. One analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $107.67.

Remove Ads

Insiders Place Their Bets

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the company's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 2.10% of the company's stock.

Encompass Health Stock Performance

Shares of EHC traded down $0.96 during mid-day trading on Tuesday, hitting $102.30. 775,382 shares of the company's stock were exchanged, compared to its average volume of 662,645. The firm has a market cap of $10.30 billion, a price-to-earnings ratio of 22.94, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a 52 week low of $78.53 and a 52 week high of $105.23. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The stock's 50-day simple moving average is $99.66 and its 200-day simple moving average is $98.11.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, equities research analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. Encompass Health's dividend payout ratio (DPR) is presently 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.